Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is Bellevue Group

Bellevue Group AG trimmed its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 5.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,430,500 shares of the company’s stock after selling 153,050 shares during the period. Neurocrine […]

Related Keywords

United States , Eric Benevich , Neurocrine Biosciences , Stephena Sherwin , Citigroup , Bellevue Group , Wealth Alliance , Barclays , Hightower Advisors , Janney Montgomery Scott , Charles Schwab Investment Management Inc , Neurocrine Biosciences Company Profile , Nasdaq , Pathstone Family Office , Neurocrine Biosciences Inc , Exchange Commission , Wells Fargo Company , Free Report , Montgomery Scott , Schwab Investment Management , Family Office , Tower Advisors , Director Stephen , Biosciences Trading Down , Get Free Report , Visit Holdingschannel , Neurocrine Biosciences Daily ,